MGMT and glioma: Unfortunately, we did not detect significant CD73/NT5E expression in any myeloid cells in our dataset nor those of Neftel et al. Independently, we identified five (when confounding factors such as IDH mutation and MGMT methylation status are accounted for) macrophage subtypes that are prognostic of glioma patient survival.